TSE:WLLW Willow Biosciences - WLLW Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Willow Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. C$0.12 0.00 (0.00%) (As of 02/3/2023 12:00 AM ET) Add Compare Share Share Today's RangeC$0.12▼C$0.1350-Day RangeC$0.11▼C$0.1352-Week RangeC$0.11▼C$0.47Volume115,525 shsAverage Volume52,368 shsMarket CapitalizationC$15.47 millionP/E Ratio4.17Dividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlinesSocial Media About Willow Biosciences (TSE:WLLW) StockWillow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.Read More Receive WLLW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Willow Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address WLLW Stock News HeadlinesFebruary 2, 2023 | msn.comThe Willow Project moves a step forward toward developmentJanuary 30, 2023 | msn.comWillow Features A Much-Needed Return To Classic Action ScenesFebruary 5, 2023 | Wall Street Watch Dogs (Ad)A gold storm is coming…“We are in the early stages of a mania – the calm before the storm.”...January 28, 2023 | msn.comWhy Willow Deserves a Season 2January 27, 2023 | msn.comBiden confirms that White House cat Willow has 'no limits' and sleeps on top of his head at nightJanuary 24, 2023 | msn.comWillow Nightingale Offers Her Thoughts On Rampage Street Fight And Resulting BacklashJanuary 21, 2023 | msn.com‘Willow’ EP Ron Howard Talks Season Two Renewal Chances, the Future of ‘Solo’ and the Time He Met Joseph CampbellJanuary 19, 2023 | msn.comWillow: How Kit and Airk Mirror Their ParentsFebruary 5, 2023 | Wall Street Watch Dogs (Ad)A gold storm is coming…“We are in the early stages of a mania – the calm before the storm.”...January 18, 2023 | msn.comWillow: Behind the Magic Documentary to Premiere on Disney+January 18, 2023 | msn.comCalgary Co-op buys Willow Park Wines and SpiritsJanuary 18, 2023 | msn.com‘Willow’ Showrunner Jonathan Kasdan on Season 2 Chances for Disney+ Series: ‘We Think There’s a Shot’January 18, 2023 | msn.comThe Decision Willow Writer Jon Kasdan Knew Would Be Divisive For FansJanuary 18, 2023 | msn.com‘General Hospital’: Most Fans Don’t Feel Sympathy for WillowJanuary 17, 2023 | msn.comWillow Showrunner Jon Kasdan Finds Peace In Knowing Fans Are Impossible To Please [Exclusive]January 17, 2023 | msn.comBreast pump maker Willow now has an Apple Watch appJanuary 17, 2023 | msn.comThe Willow breast pump now has an Apple Watch app to make pumping slightly less terribleJanuary 17, 2023 | proactiveinvestors.comWillow Biosciences announces follow-on engagement with Sandhill OneJanuary 16, 2023 | msn.comDisney+’s ‘Willow’: Here’s Why Princess Kit Tanthalos, AKA Ruby Cruz, Looks So FamiliarJanuary 16, 2023 | msn.comWillow Subverts Its Han Solo ClichéJanuary 14, 2023 | msn.comParents of Baby Willow speak out about the trialJanuary 14, 2023 | msn.comWillow Season 1 Finale's Real Stars Are the MonstersJanuary 13, 2023 | msn.comWillow Showrunner Has Hopes For What Fans Take From The Season FinaleJanuary 12, 2023 | msn.comWillow's Crone Unleashes the Sauron Fight LOTR Never Gave UsJanuary 12, 2023 | msn.comWillow Season 1: Our Biggest Unanswered Questions After the FinaleJanuary 11, 2023 | forbes.com‘Willow’ Season 1 Finale Review: This Show Could Have Been GreatJanuary 11, 2023 | msn.comThe Willow Finale Has an End Credits Reveal Hinting at the Series' FutureSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive WLLW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Willow Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolTSE:WLLW CUSIPN/A CIKN/A Webwww.willowbio.com Phone403 910 5140FaxN/AEmployees42Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio4.17 Forward P/E Ratio6.49 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio2.14 Current Ratio19.96 Quick Ratio19.71 Sales & Book Value Annual SalesC$320,000.00 Price / Sales48.33 Cash FlowC$0.15 per share Price / Cash Flow0.83 Book ValueC$0.17 per share Price / Book0.74Miscellaneous Outstanding Shares123,720,000Free FloatN/AMarket CapC$15.47 million OptionableNot Optionable BetaN/A Key ExecutivesDr. Peter Seufer-Wasserthal Ph.D. (Age 60)Pres, CEO & Chairman Comp: $55kMr. Travis Doupe (Age 50)Chief Financial Officer Comp: $292.96kDr. Chris SavileChief Operations OfficerMr. Simon Hickling Ph.D.Sr. VP of Bus. Devel.Dr. Trish ChoudharyVP of R&DMr. Troy T. TalkkariVP of Corp. Devel.Mr. Sanjib Singh Gill L.L.B. (Age 46)Corp. Sec. More ExecutivesKey Competitors48North CannabisCVE:NRTHNuvo PharmaceuticalsTSE:MRVDelta 9 CannabisTSE:DNIndivaCVE:NDVAFlowrCVE:FLWRView All CompetitorsInsiders & InstitutionsPeter Seufer-WasserthalBought 100,000 shares on 11/11/2022Total: C$13,500.00 ($0.14/share)Christopher Kenneth SavileBought 30,000 shares on 9/9/2022Total: C$4,650.00 ($0.16/share)Travis DoupeBought 200,000 shares on 8/25/2022Total: C$22,000.00 ($0.11/share)View All Insider Transactions WLLW Stock - Frequently Asked Questions How have WLLW shares performed in 2023? Willow Biosciences' stock was trading at C$0.12 on January 1st, 2023. Since then, WLLW shares have increased by 8.7% and is now trading at C$0.13. View the best growth stocks for 2023 here. What other stocks do shareholders of Willow Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Willow Biosciences investors own include Dynavax Technologies (DVAX), Heat Biologics (HTBX), VEON (VEON), Vaxart (VXRT), Wajax (WJX), Aerie Pharmaceuticals (AERI), Acasti Pharma (ACST), BlackBerry (BB) and Canadian Western Bank (CWB). What is Willow Biosciences' stock symbol? Willow Biosciences trades on the Toronto Stock Exchange (TSX) under the ticker symbol "WLLW." How do I buy shares of Willow Biosciences? Shares of WLLW stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Willow Biosciences' stock price today? One share of WLLW stock can currently be purchased for approximately C$0.13. How much money does Willow Biosciences make? Willow Biosciences (TSE:WLLW) has a market capitalization of C$15.47 million and generates C$320,000.00 in revenue each year. How can I contact Willow Biosciences? The official website for the company is www.willowbio.com. The company can be reached via phone at 403 910 5140. This page (TSE:WLLW) was last updated on 2/5/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.